La comprensión temprana Organogenesis Usando una simplificado<em> In Situ</em> Protocolo de hibridación en<em> Xenopus</em

Summary

The Xenopus laevis embryo continues to be exceptionally useful in the study of early development due to its large size and ease of manipulation. A simplified protocol for whole mount in situ hybridization protocol is provided that can be used in the identification of specific organs in this model system.

Abstract

Organogenesis is the study of how organs are specified and then acquire their specific shape and functions during development. The Xenopuslaevis embryo is very useful for studying organogenesis because their large size makes them very suitable for identifying organs at the earliest steps in organogenesis. At this time, the primary method used for identifying a specific organ or primordium is whole mount in situ hybridization with labeled antisense RNA probes specific to a gene that is expressed in the organ of interest. In addition, it is relatively easy to manipulate genes or signaling pathways in Xenopus and in situ hybridization allows one to then assay for changes in the presence or morphology of a target organ. Whole mount in situ hybridization is a multi-day protocol with many steps involved. Here we provide a simplified protocol with reduced numbers of steps and reagents used that works well for routine assays. In situ hybridization robots have greatly facilitated the process and we detail how and when we utilize that technology in the process. Once an in situ hybridization is complete, capturing the best image of the result can be frustrating. We provide advice on how to optimize imaging of in situ hybridization results. Although the protocol describes assessing organogenesis in Xenopus laevis, the same basic protocol can almost certainly be adapted to Xenopus tropicalis and other model systems.

Introduction

The expression pattern of a specific gene is an important piece of information in determining the potential role for that gene in the development of a specific organ or cell type. Simply put, if it is not expressed at the right time and place it is unlikely to play a key role. In Xenopus, as in most early embryos, the most commonly used assay for detecting the expression of a gene is whole mount in situ hybridization using labeled antisense RNA probes. The use of antibody staining to assess expression of a gene in Xenopus is becoming more common as researchers discover antibodies, usually raised against mammalian proteins, that cross react to the Xenopus homologue or generate their own ^1-3. However, the vast majority of studies on Xenopus organogenesis still utilize antisense RNA probes. When antibodies are used, each individual antibody often requires optimization for the primary antibody concentration or fixation protocols. In contrast, the protocol for in situ hybridizations is essentially invariant for different probes. The basic concept is relatively simple and an excellent standard protocol has been well established ⁴. Our protocol is a streamlined version of the original protocol ⁴ that still provides excellent detection of gene expression patterns in the early embryo. The embryos are fixed and then prepared for hybridization by changing solutions and temperatures such that it allows for high stringency binding of the labeled antisense RNA probe to its target mRNA. The unbound probe is washed away and the embryos are then prepared for binding of an antibody against the label on the RNA probes. Excess antibody is then washed away and an enzymatic color reaction is used to localize where the RNA probe is bound in the embryo. There are now a number of Xenopus transgenic lines that drive expression of fluorescent proteins in specific tissues and these are available at the Xenopus stock centers such as the National Xenopus Resource in Woods Hole. While very useful for many experiments that require examining organogenesis in living embryos, this option requires separate housing for the transgenic lines.

In situ hybridization can clearly delineate where specific organs or cell types will form in the early embryo (Figure 1). The technique is remarkably sensitive given that one can detect gene expression in a small number of cells in a single embryo ⁵. However, in situ hybridization using the intensity of colorimetric staining is not considered quantifiable because the color reaction is not a linear one. Despite difficulty in quantifying staining intensity, changes in expression are often quite noticeable; particularly when the in situ hybridization shows quantifiable increases or decreases in the size of expression domains ^6,7.

The clear advantages of whole mount in situ hybridization make it a critical assay in the study of early development. However, it is a time consuming one that requires many steps over several days. This protocol is a simplified version of the standard protocol that eliminates several steps without reducing the quality of the in situ result. The simplification also eliminates sources of variability, making trouble shooting easier if an in situ hybridization is not optimal. Specifically, we have eliminated the use of proteinase K and RNAse treatments of the embryo, two steps that can depend on reagent quality and can also reduce signal intensity if overdone. The protocol also provides some degree of cost saving due to eliminating the use of several reagents. Finally, this protocol also provides some simple guidelines for improved capturing of images of in situ hybridization results. Although this protocol is optimized for work in Xenopus embryos, it is likely that at least some of the simplifications will be applicable to in situ hybridization work in other embryo systems.

Protocol

1. Preparación de embriones Si no se hace rutinariamente como parte del cultivo de embriones, de-jalea los embriones utilizando 2,5% de cisteína, pH 8,0 antes de la fijación 8. Aunque no es absolutamente necesario, es útil a continuación, quitar manualmente el sobre fertilización antes de la fijación utilizando unas pinzas finas. Utilice pipetas Pasteur de vidrio para transferir los embriones. La pipeta no es lo suficientemente amplia como para transferir los embriones a fin de util…

Representative Results

El uso de sondas específicas de tejido puede proporcionar información relevante en cuanto a la situación del desarrollo de órganos específicos. En los siguientes ejemplos, la etapa del embrión se basa en la tabla de etapas Nieuwkoop y Faber 11. Si uno utiliza genes forman sondas expresadas después de la diferenciación, la troponina I cardiaca en etapa de 28 a 30, por ejemplo (Figura 1C), la presencia o el tamaño de un órgano diferenciado se pueden evaluar en cualquier difer…

Discussion

La capacidad de utilizar la hibridación in situ para visualizar el patrón de expresión de genes específicos sigue siendo el método más comúnmente utilizado para identificar órganos específicos o tipos de células en el embrión de Xenopus. Esto es debido a varias ventajas ofrecidas por esta técnica. La expresión de un gen puede identificar estructuras específicas así antes de cualquier signo histológico de diferenciación como es el caso para la expresión nkx2.5 en los progenito…

Materials

Name of the reagent or equipment	Company	Catalogue number
Labguake Tube Shakers	VWR	17-08-2011
VWR Vials	VWR	10-07-2012
L-Cysteine	BioShop	CYS342.500
Ribonucleoside Triphosphate Set, 100mM	Roche	11277057001
Digoxigenin-11-UTP	Roche	11209256910
Rnase inhibator (Rnase OUT)	Invitrogen	10777-019
T7 RNA Polymerase	Fermentas	EPO111
T3 RNA Polymerase	Fermentas	EPO101
SP6 RNA Polymerase	Fermentas	EPO131
Dnase 1	Invitrogen	18047-019
Sheep Serum	Wisent	31150
Blocking reagent	Roche	11096176001
BM purple Ap Substrate	Roche	11442094001
Anti-Digoxigenin-Ap Feb fragments	Roche	11093274910
Methanol	VWR	CAMX0485-7
NaCl	BioShop	SOD002.10
SDS	EM	7910
EDTA	BioShop	EDT001.500
Tris	BioShop	TRS003.5
Tween-20	EM	9480
MgSO4	Sigma	M-2643
Mops	BioShop	MOP001.250
EGTA	Sigma	E-3889-25G
Paraformaldehyde	BioShop	PAR070.500
Formamide	VWR	CAFX0420-4
RNA	Roche	10109223001
Maleic Acid	VWR	CAMX0100-3
tri-Sodium Citrate	BioShop	CIT001
Hydrogen Peroxide (30% Solution)	EM	HX0635-2
BSA	BioShop	ALB001.100
PVP-40	ICN	195451
Ficoll 400	GE Healthcare	17-0300-10
Benzyl Alcohol	Sigma	B-1042
Benzyl Benzoate	Sigma	B-6630
UltraPure Agarose	Invitrogen	16500-500